tradingkey.logo
tradingkey.logo
Suchen

BlackRock Corporate High Yield Rights Expiry 26 January 2026 When Issued

HYT_r_w
Zur Watchlist hinzufügen
0.011USD
0.0000.00%
Trading geöffnet ETKurse um 15 Minuten verzögert
1.67BMarktkapitalisierung
--KGV TTM

BlackRock Corporate High Yield Rights Expiry 26 January 2026 When Issued

0.011
0.0000.00%

mehr Informationen über BlackRock Corporate High Yield Rights Expiry 26 January 2026 When Issued Unternehmen

BlackRock Corporate High Yield Fund, Inc. (the Trust) is a diversified, closed-end management investment company. The Trust's primary investment objective is to provide shareholders with current income. The Trust’s secondary investment objective is to provide shareholders with capital appreciation. The Trust seeks to achieve its objectives by investing primarily in a diversified portfolio of fixed income securities which are rated at the time of investment to be below investment grade or, if unrated, are considered by the investment adviser to be of comparable quality. The Trust may invest directly in fixed income securities or synthetically through the use of derivatives. The Trust's investments include corporate bonds, floating rate loan interests, preferred securities and others. Its manager is BlackRock Advisors, LLC.

BlackRock Corporate High Yield Rights Expiry 26 January 2026 When Issued Informationen

BörsenkürzelHYT_r_w
Name des UnternehmensBlackRock Corporate High Yield Fund Inc
IPO-datumMay 28, 2003
CEOPerlowski (John M)
Anzahl der mitarbeiter- -
WertpapierartRight
Geschäftsjahresende- -
Addresse100 Bellevue Pkwy
StadtWILMINGTON
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl19809
Telefon18004417762
Websitehttps://www.blackrock.com/investing/products/240182/blackrock-corporate-high-yield-fund-vi-inc-usd
BörsenkürzelHYT_r_w
IPO-datumMay 28, 2003
CEOPerlowski (John M)

Führungskräfte von BlackRock Corporate High Yield Rights Expiry 26 January 2026 When Issued

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. W. Carl Kester
Dr. W. Carl Kester
Non-Executive Independent Vice Chairman of the Board of Trustee
Non-Executive Independent Vice Chairman of the Board of Trustee
--
--
Mr. Jay M. Fife
Mr. Jay M. Fife
Treasurer
Treasurer
--
--
Dr. Robert Glenn Hubbard, Ph.D.
Dr. Robert Glenn Hubbard, Ph.D.
Non-Executive Independent Chairman of the Board of Trustee
Non-Executive Independent Chairman of the Board of Trustee
--
--
Mr. John M. Perlowski
Mr. John M. Perlowski
President, Chief Executive Officer, Trustee
President, Chief Executive Officer, Trustee
--
--
Ms. Janey Ahn
Ms. Janey Ahn
Secretary
Secretary
--
--
Ms. Cynthia L. Egan
Ms. Cynthia L. Egan
Independent Trustee
Independent Trustee
--
--
Ms. Catherine A. Lynch
Ms. Catherine A. Lynch
Independent Trustee
Independent Trustee
--
--
Mr. Robert W. Fairbairn
Mr. Robert W. Fairbairn
Trustee
Trustee
--
--
Mr. Trent W. Walker
Mr. Trent W. Walker
Chief Financial Officer
Chief Financial Officer
--
--
Mr. J. Phillip Holloman
Mr. J. Phillip Holloman
Independent Trustee
Independent Trustee
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. W. Carl Kester
Dr. W. Carl Kester
Non-Executive Independent Vice Chairman of the Board of Trustee
Non-Executive Independent Vice Chairman of the Board of Trustee
--
--
Mr. Jay M. Fife
Mr. Jay M. Fife
Treasurer
Treasurer
--
--
Dr. Robert Glenn Hubbard, Ph.D.
Dr. Robert Glenn Hubbard, Ph.D.
Non-Executive Independent Chairman of the Board of Trustee
Non-Executive Independent Chairman of the Board of Trustee
--
--
Mr. John M. Perlowski
Mr. John M. Perlowski
President, Chief Executive Officer, Trustee
President, Chief Executive Officer, Trustee
--
--
Ms. Janey Ahn
Ms. Janey Ahn
Secretary
Secretary
--
--
Ms. Cynthia L. Egan
Ms. Cynthia L. Egan
Independent Trustee
Independent Trustee
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von BlackRock Corporate High Yield Rights Expiry 26 January 2026 When Issued?

Die fünf größten Anteilseigner von BlackRock Corporate High Yield Rights Expiry 26 January 2026 When Issued sind: Dr. W. Carl Kester